A Study of Amivantamab and Lazertinib Combination Therapy Versus Osimertinib in Locally Advanced or Metastatic Non-Small Cell Lung Cancer ~37 mi. (Yuma, Arizona, +258 more cities) Yuma Regional Medical Center EGFR Exon 19 Deletion, +1 more biomarker Non-Small Cell Lung Carcinoma amivantamab, +1 more drug targeted therapy
Phase 3 Study of Sitravatinib Plus Nivolumab vs Docetaxel in Patients With Advanced Non-Squamous Non-Small Cell Lung Cancer ~37 mi. (Yuma, Arizona, +206 more cities) Yuma Regional Medical Center Non-Squamous Non-Small Cell Lung Carcinoma nivolumab, +1 more drug immunotherapy, +1 more type
An Open-label Study of Encorafenib + Binimetinib in Patients With BRAFV600-mutant Non-small Cell Lung Cancer ~37 mi. (Yuma, Arizona, +108 more cities) Yuma Regional Medical Center Cancer Center, +2 more facilities BRAF V600E Non-Small Cell Lung Carcinoma binimetinib, +1 more drug targeted therapy
Tavo and Pembrolizumab in Patients With Stage III/IV Melanoma Progressing on Pembrolizumab or Nivolumab Treatment ~37 mi. (Yuma, Arizona, +36 more cities) Yuma Regional Medical Center, Yuma Cancer Center Melanoma pembrolizumab, +1 more drug immunotherapy
Study of Belantamab Mafodotin Plus Standard of Care (SoC) in Newly Diagnosed Multiple Myeloma ~37 mi. (Yuma, Arizona, +34 more cities) GSK Investigational Site Multiple Myeloma belantamab mafodotin, +3 more drugs chemotherapy, +2 more types
Cancer Search
